In 2005, Lessard and colleagues reported investigations on the expression of multiple NF-κB subunits in prostate cancer tissue arrays; they found nuclear subunit combinations such as RelB–P100/P52 and RelA–RelB, introducing for the first time a different NF-κB pattern associated with the progression of the disease [39]. Here, NFKB2 is linked to prostate carcinoma.